Half-Dose Sugammadex After Neostigmine Versus Neostigmine as a Routine Reversal Agent: A Pilot Randomized Trial
JOURNAL OF PERIANESTHESIA NURSING, cilt.37, sa.3, ss.326-332, 2022 (SCI-Expanded, SSCI, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 37 Sayı: 3
- Basım Tarihi: 2022
- Doi Numarası: 10.1016/j.jopan.2021.09.009
- Dergi Adı: JOURNAL OF PERIANESTHESIA NURSING
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus, CINAHL, EMBASE, MEDLINE, DIALNET
- Sayfa Sayıları: ss.326-332
- Anahtar Kelimeler: sugammadex, neostigmine, neuromuscular blockade, residual neuromuscular blockade, postoperative complications
- Dokuz Eylül Üniversitesi Adresli: Evet
Özet
Purpose: The use of sugammadex at a lower dose after a routine reversal dose of neostigmine may prevent residual neuromuscular blockade (rNMB). Our goal was to investigate the effects of the use of half-dose sugammadex for reversing rNMB after administration of neostigmine, and compare these effects to a routine full-dose of neostigmine.